戻る
VIA Pharmaceuticals Inc (VIAP) 収入
VIAP 株価推移チャート
VIAP 収入
VIA Pharmaceuticals Inc
$0
0%
$0
終値： Mar 27, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：Mar 27, 20:00:00 GMT-4
データなしEarnings FAQ
VIAPの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
VIA Pharmaceuticals Inc VIAPの前四半期の収益はどうでしたか？
VIA Pharmaceuticals Incの収益見積もりはいくらですか？
VIA Pharmaceuticals Incの収益品質スコアはどれくらいですか？
VIA Pharmaceuticals Incはいつ収益を報告しますか？
VIA Pharmaceuticals Incの予想収益はいくらですか？
VIA Pharmaceuticals Incは収益予想を上回りましたか？
主要データ
前終値
$0.0005
始値
$0
当日レンジ
$0 - $0.0005
52週レンジ
$0 - $0.0005
取引高
700
平均取引高
0
配当利回り
--
1株当たり利益(TTM)
-0.47
時価総額
$10.2K
VIAPとは何ですか？
VIA Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of compounds for the treatment of cardiovascular diseases. The company is headquartered in San Francisco, California and currently employs 6 full-time employees. The company went IPO on 2000-04-18. The Company’s lead compound, VIA-2291, targets an unmet medical need of reducing atherosclerotic plaque inflammation, which is an underlying cause of atherosclerosis and its complications. Atherosclerosis is a cardiovascular disease that results from chronic inflammation and the build-up of plaque in arterial blood vessel walls. The Company’s clinical development strategy integrates several technologies to provide clinical proof-of-concept, as early as possible in the clinical development process. These technologies include the measurement of biomarkers, medical imaging of the coronary and carotid vessel walls to evaluate the plaque characteristics, and atherosclerotic plaque bioassays.